InVivo Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVIV and other ETFs, options, and stocks.About NVIV
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.
CEORichard Toselli
CEORichard Toselli
Employees7
Employees7
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2005
Founded2005
Employees7
Employees7
NVIV Key Statistics
Market cap4.21M
Market cap4.21M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume174.37K
Average volume174.37K
High today$2.39
High today$2.39
Low today$2.15
Low today$2.15
Open price$2.22
Open price$2.22
Volume33.31K
Volume33.31K
52 Week high$16.00
52 Week high$16.00
52 Week low$2.01
52 Week low$2.01
NVIV Earnings
-$2.25
-$1.50
-$0.75
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 6, After Hours
ActualExpected Mar 6, After Hours